Search tips
Search criteria 


Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 1995 January; 71(1): 83–91.
PMCID: PMC2033467

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer.


Meta-analysis of the published results from 54 randomised controlled trials of adjuvant chemotherapy in head and neck cancer suggests that chemotherapy might increase absolute survival by 6.5% (95% confidence interval 3.1-9.9%). The odds ratio in favour of chemotherapy is 1.37 (95% confidence interval 1.24-1.5). Single-agent chemotherapy given synchronously with radiotherapy increased survival by 12.1% (95% confidence interval 5-19%). The benefit from neoadjuvant chemotherapy was less: a rate difference of 3.7% (95% confidence interval 0.9-6.5%). The results suggest that the investigation of optimal agents and scheduling for synchronous radiotherapy and chemotherapy might still be important in clinical trials in head and neck cancer.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA. 1992 Jul 8;268(2):240–248. [PubMed]
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. [PubMed]
  • Detsky AS, Sackett DL. When was a "negative" clinical trial big enough? How many patients you needed depends on what you found. Arch Intern Med. 1985 Apr;145(4):709–712. [PubMed]
  • Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst. 1993 Jan 20;85(2):95–111. [PubMed]
  • Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992 Jul 23;327(4):248–254. [PubMed]
  • Peto J, Easton D. Cancer treatment trials--past failures, current progress and future prospects. Cancer Surv. 1989;8(3):511–533. [PubMed]
  • Stell PM. Adjuvant Chemotherapy in Head and Neck Cancer. Semin Radiat Oncol. 1992 Jul;2(3):195–205. [PubMed]
  • Stell PM, Rawson NS. Adjuvant chemotherapy in head and neck cancer. Br J Cancer. 1990 May;61(5):779–787. [PMC free article] [PubMed]
  • Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet. 1993 Feb 13;341(8842):418–422. [PubMed]
  • Tannock IF, Browman G. Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. J Clin Oncol. 1986 Jul;4(7):1121–1126. [PubMed]
  • Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27(2):131–146. [PubMed]
  • Arcangeli G, Nervi C, Righini R, Creton G, Mirri MA, Guerra A. Combined radiation and drugs: the effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer. Radiother Oncol. 1983 Nov;1(2):101–107. [PubMed]
  • Bachaud JM, David JM, Boussin G, Daly N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys. 1991 Feb;20(2):243–246. [PubMed]
  • Bezwoda WR, de Moor NG, Derman DP. Treatment of advanced head and neck cancer by means of radiation therapy plus chemotherapy--a randomised trial. Med Pediatr Oncol. 1979;6(4):353–358. [PubMed]
  • Brunin F, Rodriguez J, Jaulerry C, Jouve M, Pontvert D, Point D, Mosseri V, Pouillart P, Asselain B, Brugere J, et al. Induction chemotherapy in advanced head and neck cancer. Preliminary results of a randomized study. Acta Oncol. 1989;28(1):61–65. [PubMed]
  • Eschwege F, Sancho-Garnier H, Gerard JP, Madelain M, DeSaulty A, Jortay A, Cachin Y. Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer. NCI Monogr. 1988;(6):275–278. [PubMed]
  • Fazekas JT, Sommer C, Kramer S. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx. Int J Radiat Oncol Biol Phys. 1980 May;6(5):533–541. [PubMed]
  • FLETCHER GH, SUIT HD, HOWE CD, SAMUELS M, JESSE RH, Jr, VILLAREAL RU. Clinical method of testing radiation-sensitizing agents in squamous cell carcinoma. Cancer. 1963 Mar;16:355–363. [PubMed]
  • Fu KK, Phillips TL, Silverberg IJ, Jacobs C, Goffinet DR, Chun C, Friedman MA, Kohler M, McWhirter K, Carter SK. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol. 1987 Sep;5(9):1410–1418. [PubMed]
  • Gollin FF, Ansfield FJ, Brandenburg JH, Ramirez G, Vermund H. Combined therapy in advanced head and neck cancer: a randomized study. Am J Roentgenol Radium Ther Nucl Med. 1972 Jan;114(1):83–88. [PubMed]
  • Gupta NK, Pointon RC, Wilkinson PM. A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin Radiol. 1987 Nov;38(6):575–581. [PubMed]
  • Holoye PY, Grossman TW, Toohill RJ, Kun LE, Byhardt RW, Duncavage JA, Teplin RW, Ritch PS, Hoffman RG, Malin TC. Randomized study of adjuvant chemotherapy for head and neck cancer. Otolaryngol Head Neck Surg. 1985 Dec;93(6):712–717. [PubMed]
  • Hussey DH, Abrams JP. Combined therapy in advanced head and neck cancer: hydroxyurea and radiotherapy. Prog Clin Cancer. 1975;6:79–86. [PubMed]
  • Jaulerry C, Rodriguez J, Brunin F, Jouve M, Mosseri V, Point D, Pontvert D, Validire P, Zafrani B, Blaszka B, et al. Induction chemotherapy in advanced head and neck tumors: results of two randomized trials. Int J Radiat Oncol Biol Phys. 1992;23(3):483–489. [PubMed]
  • Jortay A, Demard F, Dalesio O, Blanchet C, Desaulty A, Gehanno C, Lefebvre JL, Molinari R, Traissac L, Dehesdin M, et al. A randomized EORTC study on the effect of preoperative polychemotherapy in pyriform sinus carcinoma treated by pharyngolaryngectomy and irradiation. Results from 5 to 10 years. Acta Chir Belg. 1990 May-Jun;90(3):115–122. [PubMed]
  • Kapstad B, Bang G, Rennaes S, Dahler A. Combined preoperative treatment with cobalt and bleomycin in patients with head and neck carcinoma--a controlled clinical study. Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):85–89. [PubMed]
  • Keane TJ, Cummings BJ, O'Sullivan B, Payne D, Rawlinson E, MacKenzie R, Danjoux C, Hodson I. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys. 1993 Mar 15;25(4):613–618. [PubMed]
  • Kligerman MM, Hellman S, Bertino JR, Von Essen CF. Sequential chemotherapy and radiotherapy. Preliminary results of clinical trial with methotrexate in head and neck cancer. Radiology. 1966 Feb;86(2):247–250. [PubMed]
  • Knowlton AH, Percarpio B, Bobrow S, Fischer JJ. Methotrexate and radiation therapy in the treatment of advanced head and neck tumors. Radiology. 1975 Sep;116(3):709–712. [PubMed]
  • Laramore GE, Scott CB, al-Sarraf M, Haselow RE, Ervin TJ, Wheeler R, Jacobs JR, Schuller DE, Gahbauer RA, Schwade JG, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys. 1992;23(4):705–713. [PubMed]
  • Lo TC, Wiley AL, Jr, Ansfield FJ, Brandenburg JH, Davis HL, Jr, Gollin FF, Johnson RO, Ramirez G, Vermund H. Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. AJR Am J Roentgenol. 1976 Feb;126(2):229–235. [PubMed]
  • Lustig RA, DeMare PA, Kramer S. Adjuvant methotrexate in the radiotherapeutic management of advanced tumors of the head and neck. Cancer. 1976 Jun;37(6):2703–2708. [PubMed]
  • Martin M, Hazan A, Vergnes L, Peytral C, Mazeron JJ, Sénéchaut JP, Lelièvre G, Peynègre R. Randomized study of 5 fluorouracil and cis platin as neoadjuvant therapy in head and neck cancer: a preliminary report. Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):973–975. [PubMed]
  • Merlano M, Vitale V, Rosso R, Benasso M, Corvò R, Cavallari M, Sanguineti G, Bacigalupo A, Badellino F, Margarino G, et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med. 1992 Oct 15;327(16):1115–1121. [PubMed]
  • Nissenbaum M, Browde S, Bezwoda WR, de Moor NG, Derman DP. Treatment of advanced head and neck cancer: multiple daily dose fractionated radiation therapy and sequential multimodal treatment approach. Med Pediatr Oncol. 1984;12(3):204–208. [PubMed]
  • Pearlman NW, Johnson FB, Braun TJ, Kennaugh RC, Spofford BF, Borlase BC, Meyer TJ, Stiegmann GV, Meyers AD. A prospective study of preoperative chemotherapy and split-course irradiation for locally advanced or recurrent oral/pharyngeal squamous carcinoma. Am J Clin Oncol. 1985 Dec;8(6):490–496. [PubMed]
  • Petrovich Z, Block J, Kuisk H, Mackintosh R, Casciato D, Jose L, Barton R. A randomized comparison of radiotherapy with a radiotherapy--chemotherapy combination in stage IV carcinoma of the head and neck. Cancer. 1981 May 1;47(9):2259–2264. [PubMed]
  • Rentschler RE, Wilbur DW, Petti GH, Chonkich GD, Hilliard DA, Camacho ES, Thorpe RB. Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas--a prospective, randomized study. J Clin Oncol. 1987 Feb;5(2):278–285. [PubMed]
  • Richard JM, Sancho H, Lepintre Y, Rodary J, Pierquin B. Intra-arterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx. Cancer. 1974 Sep;34(3):491–496. [PubMed]
  • Richards GJ, Jr, Chambers RG. Hydroxyurea: a radiosensitizer in the treatment of neoplasms of the head and neck. Am J Roentgenol Radium Ther Nucl Med. 1969 Mar;105(3):555–565. [PubMed]
  • Sanchíz F, Millá A, Torner J, Bonet F, Artola N, Carreño L, Moya LM, Riera D, Ripol S, Cirera L. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys. 1990 Dec;19(6):1347–1350. [PubMed]
  • Schuller DE, Metch B, Stein DW, Mattox D, McCracken JD. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope. 1988 Nov;98(11):1205–1211. [PubMed]
  • Shanta V, Krishnamurthi S. Combined bleomycin and radiotherapy in oral cancer. Clin Radiol. 1980 Sep;31(5):617–620. [PubMed]
  • Siodlak MZ, Dalby JE, Bradley PJ, Campbell JB, Strickland P, Fraser JG, Willatt DJ, Flood LM, Stell PM. Induction VBM plus radiotherapy, versus radiotherapy alone for advanced head and neck cancer: long-term results. Clin Otolaryngol Allied Sci. 1989 Feb;14(1):17–22. [PubMed]
  • Stolwijk C, Wagener DJ, Van den Broek P, Levendag PC, Kazem I, Bruaset I, De Mulder PH. Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer. Neth J Med. 1985;28(9):347–351. [PubMed]
  • Szpirglas H, Chastang C, Bertrand JC. Adjvant treatment of tongue and floor of the mouth cancers. Recent Results Cancer Res. 1978;68:309–317. [PubMed]
  • Taylor SG, 4th, Applebaum E, Showel JL, Norusis M, Holinger LD, Hutchinson JC, Jr, Murthy AK, Caldarelli DD. A randomized trial of adjuvant chemotherapy in head and neck cancer. J Clin Oncol. 1985 May;3(5):672–679. [PubMed]
  • Toohill RJ, Anderson T, Byhardt RW, Cox JD, Duncavage JA, Grossman TW, Haas CD, Haas JS, Hartz AJ, Libnoch JA, et al. Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. A preliminary report. Arch Otolaryngol Head Neck Surg. 1987 Jul;113(7):758–761. [PubMed]
  • Vermund H, Kaalhus O, Winther F, Trausjø J, Thorud E, Harang R. Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial. Int J Radiat Oncol Biol Phys. 1985 Nov;11(11):1877–1886. [PubMed]
  • Von Essen CF, Joseph LB, Simon GT, Singh AD, Singh SP. Sequential chemotherapy and radiation therapy of buccal mucosa carcinoma in South India. Methods and preliminary results. Am J Roentgenol Radium Ther Nucl Med. 1968 Mar;102(3):530–540. [PubMed]
  • Ervin TJ, Clark JR, Weichselbaum RR, Fallon BG, Miller D, Fabian RL, Posner MR, Norris CM, Jr, Tuttle SA, Schoenfeld DA, et al. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol. 1987 Jan;5(1):10–20. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK